Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Salma Kodsi"'
Autor:
Salma Kodsi, Valentin Parvu, Jeffry Leitch, Devin S. Gary, Andrew Pekosz, Charles K. Cooper, Jeffrey C Andrews, Yukari C. Manabe, Celine Roger-Dalbert, Maggie Li
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases
Clinical Infectious Diseases
Background Individuals can test positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by molecular assays following the resolution of their clinical disease. Recent studies indicate that SARS-CoV-2 antigen–based tests are likely
Autor:
Edith Torres-Chavolla, Salma Kodsi, Charlotte A. Gaydos, Michael Augenbraun, Barbara Van Der Pol, Charles K. Cooper, Kenneth H. Fife, Stephanie N. Taylor, Thomas E. Davis
Publikováno v:
Sexually transmitted diseases, vol 48, iss 2
Sexually Transmitted Diseases
Sexually Transmitted Diseases
A study including female and male participants across 12 US clinics found that a triplex assay, BD CTGCTV2, performed on the benchtop BD MAX instrument, shows good performance for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichom
Autor:
Karen Eckert, Charles K. Cooper, Karen Yanson, Valentin Parvu, Mark H. Stoler, Salma Kodsi, Thomas C. Wright
Publikováno v:
Gynecologic Oncology. 153:259-265
Countries with school-based human papillomavirus (HPV) vaccination have seen significant reductions in vaccine-targeted HPV infections, cytologic abnormalities, and high-grade cervical intraepithelial neoplasia (≥CIN2). However, the impact of HPV v
Autor:
Karen Yanson, Valentin Parvu, Mark H. Stoler, Karen Eckert, Salma Kodsi, Thomas C. Wright, Charles K. Cooper
Publikováno v:
American Journal of Clinical Pathology
Objectives To determine the BD Onclarity human papillomavirus (HPV) assay performance and risk values for cervical intraepithelial neoplasia grade 2 (CIN2) or higher and cervical intraepithelial neoplasia grade 3 (CIN3) or higher during Papanicolaou/
Autor:
Valentin Parvu, Maggie Li, Devin S. Gary, Andrew Pekosz, Salma Kodsi, Jeffrey C Andrews, Charles K. Cooper, Jeffry Leitch, Celine Roger-Dalbert, Yukari C. Manabe
SUMMARYIndividuals can test positive for SARS-CoV-2 by real-time polymerase chain reaction (RT-PCR) after no longer being infectious.1-8 Positive SARS-CoV-2 antigen-based testing exhibits a temporal pattern that corresponds with active, replicating v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdd303d0f587743ae2170213618f17ef
https://doi.org/10.1101/2020.10.02.20205708
https://doi.org/10.1101/2020.10.02.20205708
Autor:
Valentin Parvu, Karen Yanson, Karen Eckert, Salma Kodsi, Charles K. Cooper, Mark H. Stoler, Thomas C. Wright
Publikováno v:
American Journal of Clinical Pathology. 151:53-62
Objectives To determine clinical utility of Onclarity human papillomavirus (HPV) assay for atypical squamous cells-undetermined significance (ASC-US) triage, and the value of HPV genotyping within ASC-US. Methods Women (n = 33,858; 21 years or older)
Autor:
Stephanie N. Taylor, Edith Torres-Chavolla, Salma Kodsi, Grace Daniel, Charles K. Cooper, Barbara Van Der Pol
Publikováno v:
Poster Presentations.
Background Numerous studies have shown that Trichomonas vaginalis (TV) infection is related to risk of HIV infection, but fewer studies have compared positivity rates based on HIV status. Further, the majority of studies that have looked at this topi
Publikováno v:
Poster Presentations.
Background The three most frequent causes of vaginitis are bacterial vaginosis (BV), vulvovaginal candidiasis (VVC) and Trichomoniasis (TV). Within women presenting with symptoms of vaginitis, the concomitant detection of two or more pathogens is com
Autor:
Jesper Bonde, Helle Krogh Pedersen, Laurence M. Vaughan, Ditte M. Ejegod, Anna Daniela Iacobone, Salma Kodsi, Fabio Landoni, Valentin Parvu, Maria Teresa Sandri, Karen Yanson, Fabio Bottari
Publikováno v:
International Journal of Cancer
Whereas HPV16 and HPV18 have been the focus in current risk‐based cervical cancer screening algorithms using HPV genotype information, mounting evidence suggests that oncogenic HPV types such as HPV31, 33, 52 and 58 pose a ≥CIN3 risk equivalent t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::269157002a7b88e8bb47acab9d3ca5d5
http://hdl.handle.net/10281/261207
http://hdl.handle.net/10281/261207
Autor:
Thomas C, Wright, Mark H, Stoler, Valentin, Parvu, Karen, Yanson, Karen, Eckert, Salma, Kodsi, Charles K, Cooper
Publikováno v:
American Journal of Clinical Pathology
Objectives To determine clinical utility of Onclarity human papillomavirus (HPV) assay for atypical squamous cells-undetermined significance (ASC-US) triage, and the value of HPV genotyping within ASC-US. Methods Women (n = 33,858; 21 years or older)